Skip to main content
TipRanks
Go Ultimate75% OFF

Diagnos (ADK) Stock Statistics & Valuation Metrics

23 Followers

Total Valuation

Diagnos has a market cap or net worth of CAD 39.74M. The enterprise value is CAD 32.59M.

Market Cap
CAD 39.74M
Enterprise Value
CAD 32.59M

Share Statistics

Diagnos has 120,412,550 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
120,412,550
Owned by Insiders
5.65%
Owned by Institutions
0.25%

Financial Efficiency

Diagnos’s return on equity (ROE) is -6.63 and return on invested capital (ROIC) is -204.11%.

Return on Equity (ROE)
-6.63
Return on Assets (ROA)
-1.91
Return on Invested Capital (ROIC)
-204.11%
Return on Capital Employed (ROCE)
-4.67
Revenue Per Employee
4,092.313
Profits Per Employee
-284.70K
Employee Count
16
Asset Turnover
0.03
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Diagnos is -7.99. Diagnos’s PEG ratio is -0.58.

PE Ratio
-7.99
PS Ratio
606.86
PB Ratio
57.85
Price to FCF
-10.28
Price to Operating Cash Flow
-10.31
PEG Ratio
-0.58

Income Statement

In the last 12 months, Diagnos had revenue of 65.48K and earned -4.56M in profits. Earnings per share was -0.04.

Revenue
65.48K
Gross Profit
-119.45K
Operating Income
-4.26M
Pretax Income
-4.56M
Net Income
-4.56M
EBITDA
-4.13M
Earnings Per Share (EPS)
-0.04

Cash Flow

In the last 12 months, operating cash flow was -3.86M and capital expenditures -11,066, giving a free cash flow of -3.87M billion.

Operating Cash Flow
-3.86M
Free Cash Flow
-3.87M
Free Cash Flow per Share
-0.03

Dividends & Yields

Diagnos pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-9.73%
Earnings Yield
-11.46%

Stock Price Statistics

Beta
0.55
52-Week Price Change
17.86%
50-Day Moving Average
0.42
200-Day Moving Average
0.31
Relative Strength Index (RSI)
32.30
Average Volume (3m)
228.48K

Important Dates

Diagnos upcoming earnings date is Dec 01, 2026, TBA (Not Confirmed).

Last Earnings Date
Aug 20, 2026
Next Earnings Date
Dec 01, 2026
Ex-Dividend Date
―

Financial Position

Diagnos as a current ratio of 1.49, with Debt / Equity ratio of 204.05%

Current Ratio
1.49
Quick Ratio
1.49
Debt to Market Cap
0.04
Net Debt to EBITDA
-0.26
Interest Coverage Ratio
-11.06

Taxes

In the past 12 months, Diagnos has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Diagnos EV to EBITDA ratio is -9.97, with an EV/FCF ratio of -10.56.

EV to Sales
623.54
EV to EBITDA
-9.97
EV to Free Cash Flow
-10.56
EV to Operating Cash Flow
-10.59

Balance Sheet

Diagnos has CAD 1.93M in cash and marketable securities with CAD 1.40M in debt, giving a net cash position of CAD 525.14K billion.

Cash & Marketable Securities
CAD 1.93M
Total Debt
CAD 1.40M
Net Cash
CAD 525.14K
Net Cash Per Share
CAD 0.00
Tangible Book Value Per Share
CAD 0.01

Margins

Gross margin is -182.42%, with operating margin of -6510.52%, and net profit margin of -6956.84%.

Gross Margin
-182.42%
Operating Margin
-6510.52%
Pretax Margin
-6956.84%
Net Profit Margin
-6956.84%
EBITDA Margin
-6251.16%
EBIT Margin
-6448.88%

Analyst Forecast

The average price target for Diagnos is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-36.92%
EPS Growth Forecast
13.03%

Scores

Smart Score
7
AI Score
43